PRIME is an EU-funded project (H2020-EU.3.1.1. - Understanding health, wellbeing and disease) and states that insulin signalling not only affects the body (e.g., diabetes and obesity) but also the brain (e.g., Alzheimer’s disease, autism and obsessive-compulsive disorders).

The EU-funded BRAINTEASER project aims to bring Artificial Intelligence home for a better care of amyotrophic lateral sclerosis and multiple sclerosis.

The “FuEl ThE bRaiN In healtThY aging and agE-relateD diseases” ETERNITY will contribute to the strengthening of the European innovation capacity by training a new generation of researchers with experience and full understanding of the requirements of academia, pharmaceutical and food supplement companies, and the society.